Association between primary hyperparathyroidism and increased body weight: A meta-analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 3, 2005, Pages 1525-1530

  Bolland, Mark J ^a   Grey, Andrew B ^a   Gamble, Greg D ^a   Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERPARATHYROIDISM; MALE; MEDLINE; PRIORITY JOURNAL; CLINICAL TRIAL; META ANALYSIS; OBESITY; PREVALENCE;

BODY WEIGHT; HUMANS; HYPERPARATHYROIDISM; OBESITY; PREVALENCE;

EID: 15944399413     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1891     Document Type: Article

References (80)

1. Adami S, Marcocci Q Gatti D 2002 Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17(Suppl 2):N18-N23
2. Melton III LJ 2002 The epidemiology of primary hyperparathyroidism in North America. J Bone Miner Res 17(Suppl 2):N12-N17
3. Palmer M, Adami HO, Bergstrom R, Jakobsson S, Akerstrom G, Ljunghall S 1987 Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up. Lancet 1:59-62
4. Palmer M, Jakobsson S, Akerstrom G, Ljunghall S 1988 Prevalence of hypercalcaemia in a health survey, a 14-year follow-up study of serum calcium values. Eur J Clin Invest 18:39-46
5. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP 1999 A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341:1249-1255
6. Lundgren E, Ljunghall S, Akerstrom G, Hetta J, Mallmin H, Rastad J 1998 Case-control study on symptoms and signs of "asymptomatic" primary hyperparathyroidism. Surgery 124:980-985
7. Ljunghall S, Palmer M, Akerstrom G, Wide L 1983 Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy. Eur J Clin Invest 13:373-377
8. Lind L, Jacobsson S, Palmer M, Lithell H, Wengle B, Ljunghall S 1991 Cardiovascular risk factors in primary hyperparathyroidism: a 15-year follow-up of operated and unoperated cases. J Intern Med 230:29-35
9. Nilsson IL, Yin L, Lundgren E, Rastad J, Ekbom A 2002 Clinical presentation of primary hyperparathyroidism in Europe: nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res 17(Suppl 2):N68-N74
10. Hedback G, Tisell LE, Bengtsson BA, Hedman I, Oden A 1990 Premature death in patients operated on for primary hyperparathyroidism. World J Surg 14:829-835
11. Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L 2003 Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 27:216-222
12. Ogard CG, Engholm G, Almdal TP, Vestergaard H 2004 Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in Denmark. World J Surg 28:108-111
13. Wajngot A, Werner S, Granberg PO, Lindvall N 1980 Occurrence of pituitary adenomas and other neoplastic diseases in primary hyperparathyroidism. Surg Gynecol Obstet 151:401-403
14. Palmer M, Adami HO, Krusemo UB, Ljunghall S 1988 Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study. Am J Epidemiol 127:1031-1040
15. Bilezikian JP, Potts Jr JT, Fuleihan Gel H, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells Jr SA 2002 Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 17(Suppl 2):N2-N11
16. Utiger RD 1999 Treatment of primary hyperparathyroidism. N Engl J Med 341:1301-1302
17. Toft AD 2000 Surgery for primary hyperparathyroidism: sooner rather than later. Lancet 355:1478-1479
18. Gough IR 2002 Primary hyperparathyroidism is a surgical condition. ANZ J Surg 72:172-173
19. Grey AB, Evans MC, Stapleton JP, Reid IR 1994 Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism. Ann Intern Med 121:745-749
20. Grey A, Reid I 1995 Body weight and bone mineral density in hyperparathyroidism. Ann Intern Med 123:732
21. Bray GA 2003 Risks of obesity. Endocrinol Metab Clin North Am 32:787-804
22. Uden P, Tibblin S 1990 Mortality in patients surgically treated for primary hyperparathyroidism due to solitary adenoma. Ann Chir Gynaecol 79:123-128
23. Hedback G, Oden A 1998 Increased risk of death from primary hyperparathyroidism: an update. Eur J Clin Invest 28:271-276
24. Valdemarsson S, Lindblom P, Bergenfelz A 1998 Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment. J Intern Med 244:241-249
25. Vestergaard P, Mosekilde L 2003 Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ 327:530-534
26. Prager R, Schernthaner G, Kovarik J, Cichini G, Klaushofer K, Willvonseder R 1984 Primary hyperparathyroidism is associated with decreased insulin receptor binding and glucose intolerance. Calcif Tissue Int 36:253-258
27. Joborn C, Rastad J, Stalberg E, Akerstrom G, Ljunghall S 1989 Muscle function in patients with primary hyperparathyroidism. Muscle Nerve 12:87-94
28. McDermott MT, Perloff JJ, Kidd GS 1994 Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy. J Bone Miner Res 9:509-514
29. Roland EJ, Wierda JM, Eurin BG, Roupie E 1994 Pharmacodynamic behaviour of vecuronium in primary hyperparathyroidism. Can J Anaesth 41:694-698
30. Dalberg K, Brodin LA, Juhlin-Dannfelt A, Farnebo LO 1996 Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study. Eur J Surg 162:171-176
31. Grey AB 1997 The skeletal effects of primary hyperparathyroidism. Baillieres Clin Endocrinol Metab 11:101-116
32. Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Heickendorff L, Mosekilde L 1999 Primary hyperparathyroidism: whole-body bone mineral density in surgically treated Danish patients: a three-year follow-up study. Bone 25:597-602
33. Duan Y, De Luca V, Seeman E 1999 Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. J Clin Endocrinol Metab 84:718-722
34. Cortet B, Cortet C, Blanckaert F, Racadot A, d'Herbomez M, Marchandise X, Dewailly D 2000 Bone ultrasonometry and turnover markers in primary hyperparathyroidism. Calcif Tissue Int 66:11-15
35. Gonnelli S, Montagnani A, Cepollaro C, Monaco R, Gennari L, Rossi B, Pacini S, Gennari C 2000 Quantitative ultrasound and bone mineral density in patients with primary hyperparathyroidism before and after surgical treatment Osteoporos Int 11:255-260
36. Ingle BM, Thomas WE, Eastell R 2002 Differential effects of primary hyperparathyroidism on ultrasound properties of bone. Osteop Int 13:572-578
37. Camozzi V, Lumachi F, Mantero F, Piccolo M, Luisetto G 2003 Phalangeal quantitative ultrasound technology and dual energy x-ray densitometry in patients with primary hyperparathyroidism: influence of sex and menopausal status. Osteoporos Int 14:602-608
38. Elvius M, Lagrelius A, Nygren A, Alveryd A, Christensson TA, Nordenstrom J 1995 Seventeen year follow-up study of borve mass in patients with mild asymptomatic hyperparathyroidism some of whom were operated on. Eur J Surg 161:863-869
39. Jorde R, Sundsfjord J 2000 Bone mineral density and blood pressure in patients with asymptomatic hyperparathyroidism. The Tromso Study. J Intern Med 247:325-330
40. Nilsson IL, Aberg J, Rastad J, Lind L 2000 Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism-effects of parathyroidectomy. Surgery 128:895-902
41. Hagag P, Revet-Zak I, Hod N, Horne T, Rapoport MJ, Weiss M 2003 Diagnosis of normocalcemic hyperparathyroidism by oral calcium loading test. J Endocrinol Invest 26:327-332
42. Fitzpatrick LA, Bilezikian JP 1987 Acute primary hyperparathyroidism. Am J Med 82:275-282
43. Loh KC, Duh QY, Shoback D, Gee L, Siperstein A, Clark OH 1998 Clinical profile of primary hyperparathyroidism in adolescents and young adults. Clin Endocrinol (Oxf) 48:435-443
44. Harman CR, van Heerden JA, Farley DR, Grant CS, Thompson GB, Curlee K 1999 Sporadic primary hyperparathyroidism in young patients: a separate disease entity? Arch Surg 134:651-655
45. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr CW 1999 Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341:1097-1105
46. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA 2001 Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161:1581-1586
47. Ni Mhurchu C, Rodgers A, Pan W, Gu D, Woodward M, on behalf of the Asia Pacific Cohort Studies Collaboration 2004 Body mass index and cardiovascular disease in the Asia-Pacific region: an overview of 33 cohorts involving 310,000 participants. Int J Epidemiol 33:751-758
48. Dyer AR, Elliott P, Shipley M 1990 Body mass index versus height and weight in relation to blood pressure. Findings for the 10,079 persons in the INTERSALT Study. The INTERSALT study: relations of body mass index to blood pressure. INTERSALT Co-operative Research Group. Am J Epidemiol 131:589-596
49. Palmer M, Adami HO, Bergstrom R, Akerstrom G, Ljunghall S 1987 Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery 102:1-7
50. Ronni-Sivula H 1985 Causes of death in patients previously operated on for primary hyperparathyroidism. Ann Chir Gynaecol 74:13-18
51. Lundgren E, Lind L, Palmer M, Jakobsson S, Ljunghall S, Rastad J 2001 Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years. Surgery 130:978-985
52. Soreide JA, van Heerden JA, Grant CS, Yau Lo C, Schleck C, Ilstrup DM 1997 Survival after surgical treatment for primary hyperparathyroidism. Surgery 122:1117-1123
53. Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodgson SF, O'Fallon WM, Melton III LJ 1998 Survival after the diagnosis of hyperparathyroidism: a population-based study. AmJ Med 104:115-122
54. Christensson T, Hellstrom K, Wengle B 1977 Blood pressure in subjects with hypercalcaemia and primary hyperparathyroidism detected in a health screening programme. Eur J Clin Invest 7:109-113
55. Bradley III EL, Wells JO 1983 Primary hyperparathyroidism and hypertension. Am Surg 49:569-570
56. Dominiczak AF, Lyall F, Morton JJ, Dargie HJ, Boyle IT, Tune TT, Murray G, Semple PF 1990 Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism. Clin Sci 78:127-132
57. Hagstrom E, Lundgren E, Lithell H, Berglund L, Ljunghall S, Hellman P, Rastad J 2002 Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin Endocrinol (Oxf) 56:253-260
58. Christensson T, Einarsson K 1977 Serum lipids before and after parathyroidectomy in patients with primary hyperparathyroidism. Clin Chim Acta 78:411-415
59. Vaziri ND, Wellikson L, Gwinup G, Byrne C 1983 Lipid fractions in primary hyperparathyroidism before and after surgical cure. Acta Endocrinol (Copenh) 102:539-542
60. Lacour B, Roullet JB, Liagre AM, Jorgetti V, Beyne P, Dubost C, Drueke T 1986 Serum lipoprotein disturbances in primary and secondary hyperparathyroidism and effects of parathyroidectomy. Am J Kidney Dis 8:422-429
61. Prager R, Schernthaner G, Niederle B, Roka R 1990 Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery. Calcif Tissue Int 46:1-4
62. Taylor WH 1991 The prevalence of diabetes mellitus in patients with primary hyperparathyroidism and among their relatives. Diabet Med 8:683-687
63. Kautzky-Willer A, Pacini G, Niederle B, Schernthaner G, Prager R 1992 Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery. Clin Endocrinol (Oxf) 37:147-155
64. Kumar S, Olukoga AO, Gordon C, Mawer EB, France M, Hosker JP, Davies M, Boulton AJ 1994 Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin Endocrinol (Oxf) 40:47-53
65. Procopio M, Magro G, Cesario F, Piovesan A, Pia A, Molineri N, Borretta G 2002 The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed type 2 diabetes mellitus in primary hyperparathyroidism. Diabet Med 19:958-961
66. Andersson P, Rydberg E, Willenheimer R 2004 Primary hyperparathyroidism and heart disease: a review. Eur Heart J 25:1776-1787
67. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ 2003 Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638
68. Christensson T, Einarsson K 1977 Cholelithiasis in subjects with hypercalcaemia and primary hvperparathyroidism detected in a health screening. Gut 18:543-546
69. Ronni-Sivula H1985 The state of health of patients previously operated on for primary hyperparathyroidism compared with randomized controls. Ann Chir Gynaecol 74:60-65
70. McCarty MF, Thomas CA 2003 PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 61:535-542
71. Civitelli R 1992 Parathyroid hormone control of intracellular calcium. J Endocrinol Invest 15:35-41
72. Dorheim MA, Sullivan M, Dandapani V, Wu X, Hudson J, Segarini PR, Rosen DM, Aulthouse AL, Gimble JM 1993 Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells. J Cell Physiol 154:317-328
73. Raisz LG, Kream BE 1983 Regulation of bone formation. N Engl J Med 309:29-35
74. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg PA, Wilske J, Bengtsson BA 1995 Serum intact parathyroid hormone in a random population sample of men and women: relationship to anthropometry, life-style factors, blood pressure, and vitamin D. Calcif Tissue Int 56:104-108
75. Jorde R, Sundsfjord J, Haug E, Bonaa KH 2000 Relation between low calcium intake, parathyroid hormone, and blood pressure. Hypertension 35:1154-1159
76. Stein MS, Flicker L, Scherer SC, Paton LM, O'Brien ML, Walton SC, Chick P, Di Carlantonio M, Zajac JD, Wark JD 2001 Relationships with serum parathyroid hormone in old institutionalized subjects. Clin Endocrinol (Oxf) 54:583-592
77. Parikh SJ, Edelman M, Uwaifo GI, Freedrnan RJ, Semega-Janneh M, Reynolds J, Yanovski JA 2004 The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89:1196-1199
78. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S 1985 Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76:370-373
79. Davies DR, Dent CE, Watson L 1968 Tertiary hyperparathyroidism. BMJ 2:395-399
80. Firth RG, Grant CS, Riggs BL 1985 Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases. Am J Med 78:669-673